A Phase 2 Study To Assess The Efficacy, Tolerability, And Safety OF NKTR-181 In Subjects With Chronic OA Knee Pain

NCT01619839 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

296

Enrollment

INDUSTRY

Sponsor class

Conditions

Osteoarthritis of the Knee

Interventions

DRUG: NKTR-181
DRUG: Placebo

Sponsor

Nektar Therapeutics